Multiple MyelomaMelphalanBoronic AcidsMyeloma ProteinsPyrazinesThalidomidePlasma CellsAntineoplastic Agents, AlkylatingTransplantation, AutologousParaproteinemiasChemotherapy, Cancer, Regional PerfusionDexamethasonePlasmacytomaLeukemia, Plasma CellMonoclonal Gammopathy of Undetermined SignificanceAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell TransplantationBone MarrowAntineoplastic AgentsSyndecan-1Myeloablative AgonistsPrednisoneParaproteinsImmunoglobulin Light ChainsCell Line, TumorAmyloidosisVincristineCombined Modality TherapyCyclophosphamideTransplantation ConditioningCarmustineBence Jones ProteinTreatment OutcomeStem Cell TransplantationRemission InductionTumor Cells, CulturedDoxorubicinProteasome InhibitorsApoptosisOsteolysisInterleukin-6Maintenance ChemotherapyDisease-Free SurvivalBone DiseasesDrug Resistance, NeoplasmPrognosisDrug SynergismSurvival AnalysisSurvival RateCell SurvivalMice, SCIDWaldenstrom MacroglobulinemiaBone Marrow CellsChromosomes, Human, Pair 14Peripheral Blood Stem Cell TransplantationRecurrenceSalvage TherapyDose-Response Relationship, DrugImmunoglobulin kappa-ChainsDiphosphonatesBusulfanSyndecansDrug Screening Assays, AntitumorImmunoglobulin lambda-ChainsThiotepaBone Marrow TransplantationGene Expression Regulation, NeoplasticTranslocation, GeneticWhole-Body IrradiationHematopoietic Stem Cell MobilizationDisease Progressionbeta 2-MicroglobulinStromal CellsTime FactorsHematologic NeoplasmsDrug Administration ScheduleTransplantation, HomologousCell ProliferationMisonidazoleFlow CytometryAlkylating AgentsProtease InhibitorsButhionine SulfoximineNitrogen Mustard CompoundsMethionine SulfoximineChromosomes, Human, Pair 13HypergammaglobulinemiaAntibodies, MonoclonalBone Marrow ExaminationNeoplasm ProteinsDrug ResistanceLymphomaRetrospective StudiesFollow-Up StudiesChromosome AberrationsReceptors, Interleukin-6Xenograft Model Antitumor AssaysEtoposideChromosomes, Human, Pair 4Immunologic Factors